• ARCA Cy5 EGFP mRNA (5-moUTP): Unveiling Cell Delivery Dynami

  2026-04-26

  Discover how ARCA Cy5 EGFP mRNA (5-moUTP), a leading 5-methoxyuridine modified mRNA, enables precise quantification and visualization of mRNA delivery, stability, and translation within mammalian cells—offering researchers novel insights into intracellular trafficking and immune evasion.

• Tubastatin A Mitigates Myocardial Injury After Cardiac Arres

  2026-04-25

  A recent preclinical study demonstrates that Tubastatin A, a selective HDAC6 inhibitor, reduces post-resuscitation myocardial injury in a porcine cardiac arrest model by suppressing pyroptosis and necroptosis. These findings highlight HDAC6 inhibition as a promising strategy for myocardial protection following ischemia-reperfusion events.

• Erastin: Precision Ferroptosis Inducer for Cancer Biology Re

  2026-04-24

  Erastin empowers researchers to model iron-dependent, non-apoptotic cell death with unprecedented selectivity in RAS/BRAF-mutant tumor cells. This guide details advanced workflows, troubleshooting strategies, and key experimental insights that position Erastin—supplied by APExBIO—as a gold-standard ferroptosis inducer for cancer biology and oxidative stress research.

• Z-VAD-FMK: Applied Workflows for Pan-Caspase Apoptosis Inhib

  2026-04-24

  Z-VAD-FMK empowers researchers to dissect apoptotic and non-apoptotic cell death mechanisms with precision and reproducibility. This article details robust experimental workflows, protocol enhancements, and evidence-driven troubleshooting strategies using APExBIO’s gold-standard inhibitor in cell-based models and translational research.

• JHU-083: Applied Workflows for Glutaminase Pathway Research

  2026-04-23

  JHU-083, a potent 6-diazo-5-oxo-L-norleucine precursor, enables selective inhibition of glutaminase activity in cerebral CD11b cells, paving the way for advanced neurological disease models. This article delivers protocol guidance, troubleshooting, and real-world applications to maximize the impact of JHU-083 in glutamate excitotoxicity research.

• Safe DNA Gel Stain: Transforming DNA and RNA Gel Visualizati

  2026-04-23

  Safe DNA Gel Stain from APExBIO redefines nucleic acid detection workflows by combining high sensitivity with an industry-leading safety profile. Its compatibility with blue-light excitation preserves DNA integrity, making it the modern standard for DNA and RNA gel staining, especially in cloning and sequencing applications.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Protocol and QC Gui

  2026-04-22

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody supports sensitive and specific detection of rabbit IgG in immunoassays such as ELISA, Western blot, IHC, and IC. It addresses the need for reliable signal amplification in workflows using rabbit primary antibodies, but should not be used in diagnostic or therapeutic settings. Researchers should carefully follow usage and storage recommendations to maintain reagent integrity.

• Innovations in In Vitro Assessment of Cancer Drug Responses

  2026-04-22

  Schwartz's dissertation introduces a dual-metric framework for in vitro drug response evaluation, distinguishing growth inhibition from cell death to better interpret anticancer efficacy. This approach clarifies the complex interplay between proliferation arrest and apoptosis, informing more precise use of PLK1 inhibitors such as BI 2536 in cancer research.

• SIRT3-SUMO Regulation of Treg Differentiation in Asthma via

  2026-04-21

  The referenced study uncovers how SIRT3-SUMO signaling orchestrates regulatory T cell (Treg) differentiation in asthma through modulation of N-glycosylation, mediated by the fatty acid oxidation (FAO) pathway. These insights clarify immune-metabolic control in asthma pathogenesis and provide a mechanistic foundation for new therapeutic strategies.

• Roscovitine (Seliciclib): Mechanistic Insight & Translationa

  2026-04-21

  This thought-leadership article dissects the mechanistic action of Roscovitine (Seliciclib, CYC202) as a selective cyclin-dependent kinase inhibitor, providing experimental guidance for translational researchers. Drawing from recent cheminformatics advances, it addresses strategic assay design, competitive positioning, and the future of small-molecule library optimization. The piece integrates evidence from both peer-reviewed research and workflow-driven resources, promoting APExBIO’s Roscovitine as a flagship reagent for cell cycle and cancer biology studies.

• Atorvastatin: Mechanistic Frontiers in Translational Researc

  2026-04-20

  Explore how Atorvastatin, a leading HMG-CoA reductase inhibitor, is redefining translational research across cholesterol metabolism, vascular biology, and ferroptosis-driven oncology. This in-depth perspective unpacks cutting-edge mechanistic evidence, strategic workflow guidance, and the unique advantages of APExBIO’s Atorvastatin (SKU: C6405), providing researchers with actionable insights beyond traditional product pages.

• Substance P Protocol Guidance for CNS and Inflammation Resea

  2026-04-20

  Substance P (SKU B6620) is a research-grade tachykinin neuropeptide used to model pain transmission, immune response modulation, and neuroinflammation via NK-1 receptor pathways. Its high water solubility and purity support reproducible assays in central nervous system and inflammation studies; however, it should not be used for diagnostic or therapeutic purposes.

• Quantifying Drug-Induced Mitotic Arrest and Death in Cancer

  2026-04-19

  Schwartz's dissertation introduces a refined framework for evaluating anti-cancer drug responses using separate metrics for proliferative arrest and cell death. This approach clarifies the kinetics and proportional contributions of growth inhibition versus cytotoxicity, enabling more precise interpretation of drug effects in vitro. The findings hold practical implications for the development and assessment of agents such as kinesin spindle protein inhibitors.

• Paclitaxel (Taxol) in Cancer Research: Applied Workflows & O

  2026-04-18

  Paclitaxel (Taxol) is a cornerstone tool for probing cell cycle arrest and apoptosis in cancer research. This article spotlights advanced experimental workflows, troubleshooting insights, and protocols that maximize the reproducibility and interpretive power of Paclitaxel-based assays. APExBIO's trusted supply ensures consistency for high-impact oncology studies.

• Inositol Phosphates Regulate Sin3L/Rpd3L HDAC Activity via S

  2026-04-17

  This study elucidates how inositol phosphates enhance deacetylase activity of the Sin3L/Rpd3L histone deacetylase complex through a zinc finger motif in the SAP30 subunit, rather than the canonical SANT domain. These findings reveal convergent regulatory mechanisms within chromatin-modifying complexes, impacting the understanding and manipulation of epigenetic regulation.

446 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page